Blog Omnicell Pharmaceutical Companies 
Omnicell
JANUARY 10, 2023
Jeff Spencer Senior Director, 340B Sales and Account Management, Omnicell Since its inception 30 years ago, the 340B Drug Pricing Program has helped non-profit healthcare organizations expand services for their communities. The pharmaceutical company notifies the hospital's drug supplier to resume supplying at a 340B discount.
Omnicell
FEBRUARY 13, 2023
Last month, a federal appeals court in Philadelphia sided largely with pharmaceutical companies in the ongoing showdown involving access to 340B discount pricing via contract pharmacies. Disclaimer The views and opinions expressed in this blog are those of the authors. The three-judge panel for the U.S. Subscribe today.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
JANUARY 10, 2023
There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website. Disclaimer The views and opinions expressed in this blog are those of the authors. 2006: Congress passed, and President George W.
Omnicell
SEPTEMBER 5, 2022
Ken Perez Vice President of Healthcare Policy, Omnicell; In Sept. Please visit Omnicell's Webinars to learn more about 340B and other healthcare topics. Add link to Omnicell's Webinars. 2020, the U.S. Census Bureau announced that the number of Americans in poverty in 2019 was 34 million, about 10.5 percent of the population.
Omnicell
MARCH 27, 2023
Ted Slafsky Founder and Principal of Wexford Solutions, Publisher, 340B Report In the past 18 months, the 340B contract pharmacy program has seemingly fractured into 17 programs, one governed by the federal government and 16 others with their own standards determined by pharmaceutical manufacturers. Subscribe today.
Omnicell
SEPTEMBER 5, 2022
Pharma’s Challenges to 340B During July and August, several large pharmaceutical companies challenged the operation of the 340B program. For more information on the programs history and a digestable synopsis of the 340B program explained , visit our blog! John Thune (R-S.D.), Debbie Stabenow (D-Mich.),
Omnicell
JANUARY 10, 2023
Ken Perez Vice President of Healthcare Policy and Government Affairs, Omnicell In August, H.R. proposed an amendment to the IRA that would have required pharmaceutical companies to rebate the government any excess costs above the negotiated prices (presumably paid by providers). Senate Majority Leader Chuck Schumer (D-N.Y.)
Expert insights. Personalized for you.
52 
Let's personalize your content